<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Certain Plant-Derived Recombinant Human Serum Albumins (“rHSA”) and Products Containing Same Notice of Commission Determination To Review the Final Initial Determination in Its Entirety; Schedule for Filing Written Submissions</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Certain Plant-Derived Recombinant Human Serum Albumins (“rHSA”) and Products Containing Same Notice of Commission Determination To Review the Final Initial Determination in Its Entirety; Schedule for Filing Written Submissions</h1>
    <p class="timestamp">Published: 2022-06-10 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>Notice is hereby given that the U.S. International Trade Commission has determined to review the final initial determination ("final ID") issued by the presiding administrative law judge ("ALJ") on April 7, 2022, in its entirety. The Commission requests briefing from the parties on certain issues under review, as indicated in this notice. The Commission also requests briefing from the parties, interested government agencies, and interested persons on the issues of remedy, the public interest, an...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> International Trade Commission</p>
    <p><strong>Document Number:</strong> 2022-12500</p>
    <p><strong>Publication Date:</strong> 2022-06-10</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/06/10/2022-12500/certain-plant-derived-recombinant-human-serum-albumins-rhsa-and-products-containing-same-notice-of">https://www.federalregister.gov/documents/2022/06/10/2022-12500/certain-plant-derived-recombinant-human-serum-albumins-rhsa-and-products-containing-same-notice-of</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-12500</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
